...
首页> 外文期刊>The American Journal of Medicine >Clinical Practice Update on Infectious Endocarditis
【24h】

Clinical Practice Update on Infectious Endocarditis

机译:感染性心内膜炎的临床实践更新

获取原文
获取原文并翻译 | 示例
           

摘要

Infectious endocarditis is a highly morbid disease with approximately 43,000 cases per year in the United States. The modified Duke Criteria have poor sensitivity; however, advances in diagnostic imaging provide new tools for clinicians to make what can be an elusive diagnosis. There are a number of risk stratification calculators that can help guide providers in medical and surgical management. Patients who inject drugs pose unique challenges for the health care system as their addiction, which is often untreated, can lead to recurrent infections after valve replacement. There is a need to increase access to medication-assisted treatment for opioid use disorders in this population. Recent studies suggest that oral and depo antibiotics may be viable alternatives to conventional intravenous therapy. Additionally, shorter courses of antibiotic therapy are potentially equally efficacious in patients who are surgically managed. Given the complexities involved with their care, patients with endocarditis are best managed by multidisciplinary teams. (C) 2019 Elsevier Inc. All rights reserved.
机译:感染性心内膜炎是一种高度病态的病态,美国每年有约43,000例。改进的公爵标准敏感性差;然而,诊断成像的进步为临床医生提供了新的工具,以使难以捉摸的诊断。有许多风险分层计算器可以帮助指导医疗和手术管理的供应商。注入药物的患者对医疗保健系统构成独特的挑战,因为他们的成瘾,通常未经治疗,可能导致阀门置换后的复发感染。需要增加对该人群的阿片类药物使用障碍的药物辅助治疗。最近的研究表明口服和Depo抗生素可能是常规静脉治疗的可行替代品。此外,在手术管理的患者中,较短的抗生素治疗疗程可能同样有效。鉴于他们的护理涉及的复杂性,心内膜炎的患者最好被多学科团队管理。 (c)2019 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号